These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12941111)

  • 1. Low-molecular-weight heparin (enoxaparin) in the treatment of lichen planus.
    Ferahbas A; Uksal U; Kutlugun C; Kontas O
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):604-5. PubMed ID: 12941111
    [No Abstract]   [Full Text] [Related]  

  • 2. The successful treatment of palmoplantar hyperkeratotic lichen planus with enoxaparin.
    Yasar S; Serdar ZA; Goktay F; Doner N; Tanzer C; Akkaya D; Gunes P
    Indian J Dermatol Venereol Leprol; 2011; 77(1):64-6. PubMed ID: 21220884
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose low-molecular-weight heparin in lichen planus.
    Rai R; Kaur I; Kumar B
    J Am Acad Dermatol; 2002 Jan; 46(1):141-3. PubMed ID: 11756963
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report.
    Hodak E; Yosipovitch G; David M; Ingber A; Chorev L; Lider O; Cahalon L; Cohen IR
    J Am Acad Dermatol; 1998 Apr; 38(4):564-8. PubMed ID: 9555795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of lichen planus with low-molecular-weight heparin (enoxaparin).
    Akdeniz S; Harman M; Atmaca S; Yaldiz M
    Int J Clin Pract; 2005 Nov; 59(11):1268-71. PubMed ID: 16236078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus.
    Stefanidou MP; Ioannidou DJ; Panayiotides JG; Tosca AD
    Br J Dermatol; 1999 Dec; 141(6):1040-5. PubMed ID: 10606849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low molecular heparin for treatment of venous thrombosis in two very low-birth-weight pre-term infants with genetic risk factors].
    Volz S; Schinzel H; Keune N; Neukirch M; Schmidtke S; Stopfkuchen H
    Klin Padiatr; 2006; 218(4):226-9. PubMed ID: 16819704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of recalcitrant lichen planus to alitretinoin in 3 patients.
    Brehmer F; Haenssle HA; Schön MP; Emmert S
    J Am Acad Dermatol; 2011 Aug; 65(2):e58-e60. PubMed ID: 21763556
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose.
    Rubboli A; Gatti C; Spinolo L; Parollo R; Spitali G; Maresta A
    Minerva Cardioangiol; 2006 Feb; 54(1):131-7. PubMed ID: 16467747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of a large clinical series: once- versus twice-daily enoxaparin for venous thromboembolism prophylaxis in high-risk trauma patients.
    Bush S; LeClaire A; Hampp C; Lottenberg L
    J Intensive Care Med; 2011; 26(2):111-5. PubMed ID: 21257630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the clinical effectiveness of an algorithmic approach for mucosal lichen planus (MLP): A retrospective review.
    Ashack KA; Haley LL; Luther CA; Riemer CA; Ashack RJ
    J Am Acad Dermatol; 2016 Jun; 74(6):1073-1076.e2. PubMed ID: 27185423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pursuing progress in acute coronary syndromes.
    Armstrong PW
    Circulation; 1999 Oct; 100(15):1586-9. PubMed ID: 10517727
    [No Abstract]   [Full Text] [Related]  

  • 13. Lichen amyloidosis improved by 0.1% topical tacrolimus.
    Castanedo-Cazares JP; Lepe V; Moncada B
    Dermatology; 2002; 205(4):420-1. PubMed ID: 12444346
    [No Abstract]   [Full Text] [Related]  

  • 14. Invited commentary.
    Henke PK
    J Vasc Surg; 2010 Nov; 52(5):1270-1. PubMed ID: 21050988
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of lichen planus with low-molecular-weight heparin: a case series of seven patients.
    Pacheco H; Kerdel F
    J Dermatolog Treat; 2001 Jun; 12(2):123-6. PubMed ID: 12243672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody.
    Parmentier L; Bron BA; Prins C; Samson J; Masouyé I; Borradori L
    Arch Dermatol; 2008 Nov; 144(11):1427-30. PubMed ID: 19015416
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate supplemented with steroid ointments for the treatment of severe erosive lichen ruber.
    Nylander Lundqvist E; Wahlin YB; Hofer PA
    Acta Derm Venereol; 2002; 82(1):63-4. PubMed ID: 12013206
    [No Abstract]   [Full Text] [Related]  

  • 18. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
    Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
    Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for Cutaneous Lichen Planus: A Systematic Review and Meta-Analysis.
    Atzmony L; Reiter O; Hodak E; Gdalevich M; Mimouni D
    Am J Clin Dermatol; 2016 Feb; 17(1):11-22. PubMed ID: 26507510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.
    Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators
    Lancet; 2001 Aug; 358(9282):605-13. PubMed ID: 11530146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.